Besides colon cancer cells, inactivating mutations in APC or the Axin tumor suppressor proteins or activating mutations in β-catenin resulting in positive effects on T-cell factor (TCF)-regulated transcription have been described in several cancer types. This evidence concerns the gene APC and colonic neoplasm.